Holdings in Company
March 11 2009 - 5:00AM
UK Regulatory
TIDMNPH TIDMDBK
RNS Number : 6668O
Neuropharm Group PLC
11 March 2009
+--------------------------------------+--------------------------------------+
| For Immediate Release | 11 March 2009 |
+--------------------------------------+--------------------------------------+
Neuropharm Group plc
("Neuropharm" or the "Company")
TR-1: Notification of Major Interests in Shares
+------------------------------------------+--------------+--------------+----------+
| 1. Identity of the issuer or the underlying issuer of | Neuropharm Group Plc |
| existing shares to which voting rights are attached: | |
+---------------------------------------------------------+-------------------------+
| 2. Reason for notification (yes/no) |
+-----------------------------------------------------------------------------------+
| An acquisition or disposal of voting rights | Yes |
+------------------------------------------------------------------------+----------+
| 3. Full name of person(s) subject to | Deutsche Bank AG |
| notification obligation: | |
+------------------------------------------+----------------------------------------+
| 4. Full name of shareholder(s) (if | |
| different from 3): | |
+------------------------------------------+----------------------------------------+
| 5. Date of transaction (and date on | 06/03/2009 |
| which the threshold is crossed or | |
| reached if different): | |
+------------------------------------------+----------------------------------------+
| 6. Date on which issuer notified: | 09/03/2009 |
| | |
+------------------------------------------+----------------------------------------+
| 7. Threshold(s) that is/are crossed or | 7% |
| reached: | |
+------------------------------------------+--------------+--------------+----------+
+---------------+-------------+-----------+-----------+-------------+----------+----------+----------+
| 8: Notified Details |
+----------------------------------------------------------------------------------------------------+
| A: Voting rights attached to shares |
| |
+----------------------------------------------------------------------------------------------------+
| Class/type | Situation previous | Resulting situation after the triggering |
| of shares | to the triggering | transaction |
| If possible | transaction | |
| use ISIN | | |
| code | | |
| | | |
+ +-------------------------+----------------------------------------------------------+
| | Number of | Number | Number | Number of voting | Percentage of |
| | shares | of | of | rights | voting rights |
| | | voting | shares | | |
| | | rights | | | |
| | | | | | |
+ + + + +------------------------+---------------------+
| | | | | Direct | Indirect | Direct | Indirect |
+---------------+-------------+-----------+-----------+-------------+----------+----------+----------+
| GB000B1NPJJ01 | 2,308,162 | 2,308,162 | 2,187,364 | 2,187,364 | | 6.94% | |
| | | | | | | | |
+---------------+-------------+-----------+-----------+-------------+----------+----------+----------+
+---------------+---------------+---------------+----------------------+---------------+
| B: Financial Instruments |
| |
+--------------------------------------------------------------------------------------+
| Resulting situation after the triggering transaction |
| |
+--------------------------------------------------------------------------------------+
| Type of | Expiration | Exercise/ | No. of voting | Percentage of |
| financial | date | conversion | rights that | voting rights |
| instrument | | period/date | may be | |
| | | | acquired (if | |
| | | | the | |
| | | | instrument | |
| | | | exercised/converted) | |
+---------------+---------------+---------------+----------------------+---------------+
| | | | | |
+---------------+---------------+---------------+----------------------+---------------+
+--------------------------------------+--------------------------------------+
| Total (A+B) |
| |
+-----------------------------------------------------------------------------+
| Number of voting rights | Percentage of voting rights |
+--------------------------------------+--------------------------------------+
| 2,187,364 | 6.94% |
+--------------------------------------+--------------------------------------+
+-----------------------------------------------------------------------------+
| 9. Chain of controlled undertakings through which the voting rights and /or |
| the financial instruments are effectively held, if applicable: |
+-----------------------------------------------------------------------------+
| |
+-----------------------------------------------------------------------------+
+--------------------------------------+--------------------------------------+
| Proxy Voting: |
+-----------------------------------------------------------------------------+
| 10. Name of proxy holder: | |
| | |
+--------------------------------------+--------------------------------------+
| 11. Number of voting rights proxy | |
| holder will cease to hold: | |
| | |
+--------------------------------------+--------------------------------------+
| 12. Date on which proxy holder will | |
| cease to hold voting rights: | |
| | |
+--------------------------------------+--------------------------------------+
| 13. Additional information: | |
| | |
+--------------------------------------+--------------------------------------+
| 14 Contact name: | David Lindsay / Andrew Anderson |
| | |
+--------------------------------------+--------------------------------------+
| 15. Contact telephone name: | + 00 44 207 545 85338532 |
| | |
+--------------------------------------+--------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAPDFFSPNEEE
Neuropharm (LSE:NPH)
Historical Stock Chart
From Jul 2024 to Aug 2024
Neuropharm (LSE:NPH)
Historical Stock Chart
From Aug 2023 to Aug 2024
